CD30 expression reveals that culture adaptation of human embryonic stem cells can occur through differing routes

Stem Cells

Volumn 27, Issue 5, 2009, Pages 1057-1065

  Harrison, Neil J ^a   Barnes, James ^a   Jones, Mark ^a   Baker, Duncan ^b   Gokhale, Paul J ^a   Andrews, Peter W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Apoptosis; CD30; Chromosomal aberrations; Culture adaptation; Embryonal carcinoma; Human embryonic stem cells

Indexed keywords

CASPASE 3; CASPASE 8; CD30 ANTIGEN; LIPOCORTIN 5;

ADAPTATION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL LINE; CELL SELECTION; CELL SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; EMBRYONIC STEM CELL; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; KARYOTYPE; WESTERN BLOTTING;

ADAPTATION, BIOLOGICAL; ANTIGENS, CD30; APOPTOSIS; CARCINOMA, EMBRYONAL; CELL SURVIVAL; CELLS, CULTURED; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HUMANS; KARYOTYPING;

EID: 66149160366     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.41     Document Type: Article

References (28)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147. (Pubitemid 28516247)
2. Draper JS, Smith K, Gokhale P et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 2004;22:53-54. (Pubitemid 38057956)
3. Enver T, Soneji S, Joshi C et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet 2005;14:3129-3140. (Pubitemid 41631288)
4. Baker DE, Harrison NJ, Maltby E et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 2007;25:207-215. (Pubitemid 46227120)
5. Herszfeld D, Wolvetang E, Langton-Bunker E et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotechnol 2006;24:351-357. (Pubitemid 43372160)
6. Pera MF, Bennett W, Cerretti DP. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors. Lab Invest 1997;76:497-504. (Pubitemid 27176104)
7. Horie R, Watanabe T. CD30: expression and function in health and disease. Semin Immunol 1998;10:457-470. (Pubitemid 28564375)
8. Horie R, Watanabe T, Morishita Y et al. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin- Reed-Sternberg cells. Oncogene 2002;21:2493-2503. (Pubitemid 34438102)
9. Duckett CS, Gedrich RW, Gilfillan MC, et al. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol Cell Biol 1997;17:1535-1542. (Pubitemid 27097383)
10. Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol 2002;35:28-40. (Pubitemid 34363111)
11. Yang S, Lin G, Tan YQ et al. Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes Chromosomes Cancer 2008;47:665-679.
12. Andrews PW, Damjanov I, Simon D et al. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 1984;50: 147-162.
13. Andrews PW, Goodfellow PN, Shevinsky LH, et al. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int J Cancer 1982;29: 523-531.
14. Liew CG, Draper JS, Walsh J, et al. Transient and stable transgene expression in human embryonic stem cells. Stem Cells 2007;25: 1521-1528.
15. Pennica D, Nedwin GE, Hayflick JS et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984;312:724-729. (Pubitemid 15195918)
16. Bertrand R, Solary E, O'Connor P, et al. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 1994;211: 314-321. (Pubitemid 24174963)
17. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005;4:139-163. (Pubitemid 41351311)
18. Lagarkova MA, Volchkov PY, Philonenko ES et al. CD 30 is a marker of undifferentiated human embryonic stem cells rather than a biomarker of transformed hESCs. Cell Cycle 2008;7:3610-3612.
19. Harrison NJ, Baker D, Andrews PW. Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int J Androl 2007;30: 275-281; discussion 281. (Pubitemid 47254405)
20. Inniss K, Moore H. Mediation of apoptosis and proliferation of human embryonic stem cells by sphingosine-1-phosphate. Stem Cells Dev 2006;15:789-796. (Pubitemid 46147851)
21. Li J, Wang G, Wang C et al. MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal. Differentiation 2007;75:299-307. (Pubitemid 46434953)
22. Qin H, Yu T, Qing T et al. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 2007;282: 5842-5852. (Pubitemid 47093795)
23. Pyle AD, Lock LF, Donovan PJ. Neurotrophins mediate human embryonic stem cell survival. Nat Biotechnol 2006;24:344-350. (Pubitemid 43372159)
24. Stojkovic M, Lako M, Strachan T, et al. Derivation, growth and applications of human embryonic stem cells. Reproduction 2004;128:259-267. (Pubitemid 39242702)
25. Gearhart J. New human embryonic stem-cell lines-more is better. N Engl J Med 2004;350:1275-1276. (Pubitemid 38375358)
26. Becker KA, Ghule PN, Therrien JA et al. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J Cell Physiol 2006;209:883-893. (Pubitemid 44665710)
27. Blank M, Shiloh Y. Programs for cell death: apoptosis is only one way to go. Cell Cycle 2007;6:686-695. (Pubitemid 46535681)
28. Sidi S, Sanda T, Kennedy RD et al. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase- 3. Cell 2008;133:864-877.